Gilotrif

Large U.S. cancer trial to match genetic glitches to targeted drugs
Yahoo/Reuters
Mon, 06/1/15 - 07:49 pm
clinical trials
Pfizer
Xalkori
Boehringer Ingelheim
Gilotrif
Roche
Kadcyla
AZD9291
AstraZeneca
VS-6063
Verastem
personalized medicine
FDA approves GILOTRIF™ (afatinib) as first-line treatment for metastatic non-small cell lung cancer with common EGFR mutations
Sacramento Bee, CA
Sat, 07/13/13 - 12:37 pm
non-small cell lung cancer
Gilotrif
Afatinib
Boehringer Ingelheim